Literature DB >> 19539630

Modeling HIV persistence, the latent reservoir, and viral blips.

Libin Rong1, Alan S Perelson.   

Abstract

HIV-1 eradication from infected individuals has not been achieved with the prolonged use of highly active antiretroviral therapy (HAART). The cellular reservoir for HIV-1 in resting memory CD4(+) T cells remains a major obstacle to viral elimination. The reservoir does not decay significantly over long periods of time but is able to release replication-competent HIV-1 upon cell activation. Residual ongoing viral replication may likely occur in many patients because low levels of virus can be detected in plasma by sensitive assays and transient episodes of viremia, or HIV-1 blips, are often observed in patients even with successful viral suppression for many years. Here we review our current knowledge of the factors contributing to viral persistence, the latent reservoir, and blips, and mathematical models developed to explore them and their relationships. We show how mathematical modeling has helped improve our understanding of HIV-1 dynamics in patients on HAART and of the quantitative events underlying HIV-1 latency, reservoir stability, low-level viremic persistence, and emergence of intermittent viral blips. We also discuss treatment implications related to these studies.

Entities:  

Mesh:

Year:  2009        PMID: 19539630      PMCID: PMC2753284          DOI: 10.1016/j.jtbi.2009.06.011

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  230 in total

Review 1.  Modelling viral and immune system dynamics.

Authors:  Alan S Perelson
Journal:  Nat Rev Immunol       Date:  2002-01       Impact factor: 53.106

Review 2.  HIV-1 pathogenesis.

Authors:  Mario Stevenson
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

Review 3.  Antiretroviral drug resistance and resistance testing.

Authors:  Joel E Gallant
Journal:  Top HIV Med       Date:  2005 Dec-2006 Jan

Review 4.  Dynamics of HIV-1 and CD4+ lymphocytes in vivo.

Authors:  A S Perelson; P Essunger; D D Ho
Journal:  AIDS       Date:  1997       Impact factor: 4.177

5.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 6.  Immunological memory and protective immunity: understanding their relation.

Authors:  R Ahmed; D Gray
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

7.  Modeling plasma virus concentration during primary HIV infection.

Authors:  M A Stafford; L Corey; Y Cao; E S Daar; D D Ho; A S Perelson
Journal:  J Theor Biol       Date:  2000-04-07       Impact factor: 2.691

8.  Human immunodeficiency virus drug therapy and virus load.

Authors:  S Bonhoeffer; J M Coffin; M A Nowak
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

9.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

10.  Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy.

Authors:  Deborah Persaud; Stuart C Ray; Joleen Kajdas; Aima Ahonkhai; George K Siberry; Kimberly Ferguson; Carrie Ziemniak; Thomas C Quinn; Joseph P Casazza; Steven Zeichner; Stephen J Gange; Douglas C Watson
Journal:  AIDS Res Hum Retroviruses       Date:  2007-03       Impact factor: 2.205

View more
  66 in total

1.  Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection.

Authors:  Nancie M Archin; Naveen K Vaidya; Joann D Kuruc; Abigail L Liberty; Ann Wiegand; Mary F Kearney; Myron S Cohen; John M Coffin; Ronald J Bosch; Cynthia L Gay; Joseph J Eron; David M Margolis; Alan S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

2.  Post-treatment control of HIV infection.

Authors:  Jessica M Conway; Alan S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

3.  Joint effects of mitosis and intracellular delay on viral dynamics: two-parameter bifurcation analysis.

Authors:  Michael Y Li; Hongying Shu
Journal:  J Math Biol       Date:  2011-06-14       Impact factor: 2.259

4.  A mathematical model of HIV dynamics in the presence of a rescuing virus with replication deficiency.

Authors:  Elias Zintzaras; Axel Kowald
Journal:  Theory Biosci       Date:  2011-01-29       Impact factor: 1.919

5.  Stochastic modelling of the eradication of the HIV-1 infection by stimulation of latently infected cells in patients under highly active anti-retroviral therapy.

Authors:  Daniel Sánchez-Taltavull; Arturo Vieiro; Tomás Alarcón
Journal:  J Math Biol       Date:  2016-02-26       Impact factor: 2.259

6.  A multi-scale mathematical modeling framework to investigate anti-viral therapeutic opportunities in targeting HIV-1 accessory proteins.

Authors:  Gajendra W Suryawanshi; Alexander Hoffmann
Journal:  J Theor Biol       Date:  2015-09-16       Impact factor: 2.691

7.  Drug-class specific impact of antivirals on the reproductive capacity of HIV.

Authors:  Max von Kleist; Stephan Menz; Wilhelm Huisinga
Journal:  PLoS Comput Biol       Date:  2010-03-26       Impact factor: 4.475

8.  Intracellular transactivation of HIV can account for the decelerating decay of virus load during drug therapy.

Authors:  Christian L Althaus; Rob J De Boer
Journal:  Mol Syst Biol       Date:  2010-02-16       Impact factor: 11.429

9.  Increased inflammation in sanctuary sites may explain viral blips in HIV infection.

Authors:  E Fabian Cardozo; Michael J Piovoso; Ryan Zurakowski
Journal:  IET Syst Biol       Date:  2016-08       Impact factor: 1.615

10.  Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.

Authors:  Libin Rong; Alan S Perelson
Journal:  PLoS Comput Biol       Date:  2009-10-16       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.